Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 7 16:05 ET

Vera Therapeutics Insider Sold Shares Worth $753,680, According to a Recent SEC Filing

MT NewswiresDec 20, 2024 16:12 ET

Vera Therapeutics (VERA) Receives a Buy From TD Cowen

TipRanksDec 11, 2024 05:48 ET · Ratings

JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG

Seeking AlphaNov 25, 2024 13:58 ET

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireNov 22, 2024 16:05 ET

Vera Therapeutics Price Target Announced at $70.00/Share by Wells Fargo

Dow JonesNov 21, 2024 08:14 ET · Ratings